cytosine has been researched along with Parkinson Disease in 10 studies
Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Certain mutations (TT homozygous; CT heterozygous; CC wild-type) of the methylenetetrahydrofolate (MTHFR) gene and long-term levodopa application in patients with Parkinson's disease (PD) support onset of hyperhomocysteinemia." | 7.72 | MTHFR C677T polymorphism, folic acid and hyperhomocysteinemia in levodopa treated patients with Parkinson's disease. ( Kuhn, W; Müller, T; Woitalla, D, 2004) |
| "Certain mutations (TT homozygous; CT heterozygous; CC wild-type) of the methylenetetrahydrofolate (MTHFR) gene and long-term levodopa application in patients with Parkinson's disease (PD) support onset of hyperhomocysteinemia." | 3.72 | MTHFR C677T polymorphism, folic acid and hyperhomocysteinemia in levodopa treated patients with Parkinson's disease. ( Kuhn, W; Müller, T; Woitalla, D, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, J | 1 |
| Dembo, RS | 1 |
| DaWalt, LS | 1 |
| Baker, MW | 1 |
| Berry-Kravis, E | 1 |
| Mailick, MR | 1 |
| Armstrong, MJ | 1 |
| Jin, Y | 1 |
| Allen, EG | 1 |
| Jin, P | 1 |
| Gopalai, AA | 1 |
| Lim, SY | 1 |
| Aziz, ZA | 1 |
| Lim, SK | 1 |
| Tan, LP | 1 |
| Chong, YB | 1 |
| Tan, CT | 1 |
| Puvanarajah, S | 1 |
| Viswanathan, S | 1 |
| Kuppusamy, R | 1 |
| Tan, AH | 1 |
| Lim, TT | 1 |
| Eow, GB | 1 |
| Norlinah, MI | 1 |
| Li, HH | 1 |
| Zhao, Y | 1 |
| Ahmad-Annuar, A | 1 |
| Zheng, T | 1 |
| Lv, Q | 1 |
| Lei, X | 1 |
| Yin, X | 1 |
| Zhang, B | 1 |
| GOMIRATO, G | 1 |
| HYDEN, H | 1 |
| Woitalla, D | 1 |
| Kuhn, W | 1 |
| Müller, T | 1 |
| Hong, CJ | 1 |
| Liu, HC | 1 |
| Liu, TY | 1 |
| Liao, DL | 1 |
| Tsai, SJ | 1 |
| Grünewald, A | 1 |
| Breedveld, GJ | 1 |
| Lohmann-Hedrich, K | 1 |
| Rohé, CF | 1 |
| König, IR | 1 |
| Hagenah, J | 1 |
| Vanacore, N | 1 |
| Meco, G | 1 |
| Antonini, A | 1 |
| Goldwurm, S | 1 |
| Lesage, S | 1 |
| Dürr, A | 1 |
| Binkofski, F | 1 |
| Siebner, H | 1 |
| Münchau, A | 1 |
| Brice, A | 1 |
| Oostra, BA | 1 |
| Klein, C | 1 |
| Bonifati, V | 1 |
| Pastor, P | 1 |
| Muñoz, E | 1 |
| Ezquerra, M | 1 |
| Obach, V | 1 |
| Martí, MJ | 1 |
| Valldeoriola, F | 1 |
| Tolosa, E | 1 |
| Oliva, R | 1 |
| Cheng, CC | 1 |
| Roth, B | 1 |
2 reviews available for cytosine and Parkinson Disease
| Article | Year |
|---|---|
Diverse and dynamic DNA modifications in brain and diseases.
Topics: Adenosine; Alzheimer Disease; Animals; Ataxia; Brain; Chromatin; Cytosine; DNA; DNA Methylation; Epi | 2019 |
Some pyrimidines of biological and medicinal interest. 3.
Topics: Alkylating Agents; Alloxan; Amino Acids; Animals; Anti-Inflammatory Agents; Anticonvulsants; Antifun | 1971 |
8 other studies available for cytosine and Parkinson Disease
| Article | Year |
|---|---|
Mortality in Women across the
Topics: Adult; Aged, 80 and over; Cognitive Dysfunction; Cytosine; Female; Fragile X Mental Retardation Prot | 2023 |
Lack of association between the LRRK2 A419V variant and Asian Parkinson's disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alanine; Case-Control Studies; China; Cohort Studies; Cy | 2013 |
Spatial distribution of 5-hydroxymethyl cytosine in rat brain and temporal distribution in striatum.
Topics: 5-Methylcytosine; Animals; Brain; Corpus Striatum; Cytosine; Male; Oxidopamine; Parkinson Disease; R | 2015 |
A BIOCHEMICAL GLIA ERROR IN THE PARKINSON DISEASE.
Topics: Adenine; Cytosine; Globus Pallidus; Guanine; Neurochemistry; Neuroglia; Neurons; Nucleic Acids; Park | 1963 |
MTHFR C677T polymorphism, folic acid and hyperhomocysteinemia in levodopa treated patients with Parkinson's disease.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Cytosine; Female; Folic Acid; Humans; Hyperhom | 2004 |
Association studies of the adenosine A2a receptor (1976T > C) genetic polymorphism in Parkinson's disease and schizophrenia.
Topics: Age Distribution; Age of Onset; Aged; Asian People; Base Sequence; Brain; Brain Chemistry; Cytosine; | 2005 |
Biological effects of the PINK1 c.1366C>T mutation: implications in Parkinson disease pathogenesis.
Topics: Base Sequence; Cytosine; DNA, Complementary; Family; Female; Genetic Carrier Screening; Homozygote; | 2007 |
Analysis of the coding and the 5' flanking regions of the alpha-synuclein gene in patients with Parkinson's disease.
Topics: Aged; Aged, 80 and over; alpha-Synuclein; Base Pair Mismatch; Case-Control Studies; Cytosine; Essent | 2001 |